Call from Friday February 6th, 2026 featuring Marianne Clancy, CEO of Cure HHT.

Ms. Clancy has been CEO of Cure HHT for 24 years. Under her leadership, she initiated the Cure HHT research grant funding program to established and young researchers. Under her tenure, through the investment of $3 Min seed grants since 2004, HHT research funding has been leveraged nearly $60M in private and public investment. She has been instrumental in providing the patient voice to the design of HHT clinical research trials.

Marianne has expanded access to expert HHT care through the establishment and management of 33 HHT Centers of Excellence in North America and 25 centers globally. Her work in obtaining release of the HHT gene patents led to the launch of genetic testing for HHT in North America. Her team has led collaborations to enable the robust growth of the International Scientific Conferences in HHT since 2001 as the sole sponsor of these convenings.

Call from Friday January 30th, 2026 featuring Dr. Martin Steinberg.

Dr. Martin Steinberg is an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. His areas of clinical expertise include adult psychiatry. He earned his M.D. from Wake Forest University. He completed a residency and a fellowship in psychiatry at the Johns Hopkins University School of Medicine.

Dr. Steinberg's interests include depression, agitation and related behavioral symptoms in Alzheimer's; the relationship between physical exercise and dementia; and dementia in the assisted living and nursing home setting.

Call from Friday January 9th, 2026 lead by our host Dr. Panagis Galiatsatos (Dr. G).

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins.

Call from Friday January 9th, 2026 featuring Dr. Natalie Exum.

Dr. Natalie Exum is a water scientist at the Johns Hopkins Bloomberg School of Public Health in the Department of Environmental Health and Engineering. Her work focuses on linking health with water and sanitation infrastructure. She is currently working on community-engaged approaches to understand how drinking water exposures in Baltimore City are affecting the health of residents.

This week we have a throwback episode due to the Holidays!

This call is from November 2024 and features Dr. Natalie Exum.

Dr. Natalie Exum is a water scientist at the Johns Hopkins Bloomberg School of Public Health in the Department of Environmental Health and Engineering. Her work focuses on linking health with water and sanitation infrastructure. She is currently working on community-engaged approaches to understand how drinking water exposures in Baltimore City are affecting the health of residents.

Call from Friday December 19th, featuring Dr. Anne Yacoub.

Anne Damian Yacoub, M.D., is a neurologist who specializes in both multiple sclerosis and headache. Her areas of expertise include the diagnosis and treatment of multiple sclerosis and other neuroimmunological disorders that involve the central nervous system. She is also an expert in acute and chronic management of headache disorders.

Dr. Yacoub earned her medical degree from the University of Arizona College of Medicine, followed by a residency in neurology at the McGill University Health Centre. Dr. Yacoub spent one year studying the diagnosis and management of headaches as a Seymour Diamond Headache Medicine fellow in a combined program at the Diamond Headache Clinic and the Loyola University Medical Center in Chicago. She subsequently trained as a clinical and research fellow in the Johns Hopkins Department of Neurology, studying neuroimmunology and neurological infections.

Dr. Yacoub's research interests include studying migraine headaches in patients with multiple sclerosis.

Call from Friday December 12th, featuring Dr. Michael Streiff.

Dr. Streiff's major clinical interest involves the prevention and treatment of venous thromboembolism. He has written several comprehensive reviews on vena caval filters and the management of venous thromboembolism in cancer patients. He chairs the Venous Thromboembolism Guideline Committee for the National Comprehensive Cancer Center Network and has served on international consensus panels to develop standardized guidelines for the use of vena caval filters in the management of venous thromboembolism. As a member of a Johns Hopkins Evidence-Based Practice Center panel, he participated in the development of evidence reports on the management of venous thromboembolism.

As Medical Director of the Anticoagulation Management Service and Outpatient Clinics, he and his colleagues from the Department of Pharmacy have been actively involved in developing policies and procedures for standardizing anticoagulation management and guidelines for VTE prevention at the Johns Hopkins Medical Institutions. As the consulting Hematologist for the Johns Hopkins Comprehensive Hemophilia Treatment Center, he is actively involved in the diagnosis and treatment of patients with hemophilia, von Willebrand disease and other hemostatic disorders.

Call from Friday December 5th, 2025 featuring Dr. Otis Brawley.

Otis Brawley is a globally-recognized expert in cancer prevention and control. He has worked to reduce overscreening of medical conditions, which has revolutionized patient treatment by increasing quality of life and reducing health disparities.

Brawley's research focuses on developing cancer screening strategies and ensuring their effectiveness. He has championed efforts to decrease smoking and implement other lifestyle risk reduction programs, as well as to provide critical support to cancer patients and concentrate cancer control efforts in areas where they could be most effective. Brawley currently leads a broad interdisciplinary research effort on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, striving to close racial, economic, and social disparities in the prevention, detection, and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland.